TW200738251A - Transcription modulator compositions - Google Patents

Transcription modulator compositions

Info

Publication number
TW200738251A
TW200738251A TW095129843A TW95129843A TW200738251A TW 200738251 A TW200738251 A TW 200738251A TW 095129843 A TW095129843 A TW 095129843A TW 95129843 A TW95129843 A TW 95129843A TW 200738251 A TW200738251 A TW 200738251A
Authority
TW
Taiwan
Prior art keywords
subject
regulated
iκb kinase
kinase subunit
transcription modulator
Prior art date
Application number
TW095129843A
Other languages
English (en)
Other versions
TWI324521B (en
Inventor
Pei-Wen Hsiao
Original Assignee
Academia Sinica
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Academia Sinica filed Critical Academia Sinica
Publication of TW200738251A publication Critical patent/TW200738251A/zh
Application granted granted Critical
Publication of TWI324521B publication Critical patent/TWI324521B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TW095129843A 2006-03-21 2006-08-14 Transcription modulator compositions TWI324521B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/386,985 US8597701B2 (en) 2006-03-21 2006-03-21 Transcription modulator compositions

Publications (2)

Publication Number Publication Date
TW200738251A true TW200738251A (en) 2007-10-16
TWI324521B TWI324521B (en) 2010-05-11

Family

ID=38533760

Family Applications (2)

Application Number Title Priority Date Filing Date
TW095129843A TWI324521B (en) 2006-03-21 2006-08-14 Transcription modulator compositions
TW098145586A TWI405966B (zh) 2006-03-21 2006-08-14 轉錄調控物組合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
TW098145586A TWI405966B (zh) 2006-03-21 2006-08-14 轉錄調控物組合物

Country Status (2)

Country Link
US (2) US8597701B2 (zh)
TW (2) TWI324521B (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9149458B1 (en) * 2015-02-03 2015-10-06 Wyntek Corporation Method for treating hypertriglyceridemia with a Wedelia chinensis extract
US10026052B2 (en) * 2016-10-03 2018-07-17 Metrics Medius, Inc. Electronic task assessment platform
CN106924240B (zh) * 2017-04-14 2019-11-19 印晓星 包含槲皮素的药物组合物及其用途
CN108178319B (zh) * 2018-01-08 2021-07-13 华南师范大学 杂交蟛蜞菊在治理镉污染水体中的应用及治理方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5130133A (en) * 1990-09-28 1992-07-14 The Procter & Gamble Company Plant extracts as mucosal-protective agents
FR2679134B1 (fr) * 1991-07-19 1993-10-22 Sablon Louis Compositions cosmetiques pour la regulation de la pigmentation cutanee comprenant un extrait d'eclipta alba.
JP3542700B2 (ja) * 1997-06-19 2004-07-14 株式会社資生堂 頭部用組成物
WO1999007381A1 (en) * 1997-08-11 1999-02-18 Weider Nutrition International, Inc. Compositions and treatments to reduce side effects of administration of androgenic testosterone precursors
JP4020285B2 (ja) * 1999-06-01 2007-12-12 株式会社マンダム 育毛剤原料及び育毛剤組成物
US20020192310A1 (en) * 2001-02-02 2002-12-19 Bland Jeffrey S. Medical composition for managing hormone balance
US20050032882A1 (en) * 2002-03-06 2005-02-10 Sophie Chen Botanical extract compositions and methods of use
CN1321639C (zh) * 2003-12-30 2007-06-20 上海安普生物科技有限公司 治疗关节炎的药物

Also Published As

Publication number Publication date
US9144591B2 (en) 2015-09-29
TW201016227A (en) 2010-05-01
US8597701B2 (en) 2013-12-03
US20070224296A1 (en) 2007-09-27
TWI324521B (en) 2010-05-11
US20140141109A1 (en) 2014-05-22
TWI405966B (zh) 2013-08-21

Similar Documents

Publication Publication Date Title
PH12012500765A1 (en) Boronic acids and esters as inhibitors of fatty acid amide hydrolase
AR112074A2 (es) Derivados de 2-carboxamida-cicloamino-urea como inhibidores de pi-3
SG151286A1 (en) 5-substituted-2-phenylamino-benzamide as mek inhibitor
MA34207B1 (fr) Inhibiteurs de la pi3 kinase et/ou du mtor
NZ580226A (en) Dimer compounds as inhibitors of iap
TW200801012A (en) Phosphoinositide 3-kinase inhibitor compounds and methods of use
DE602007006419D1 (de) Verfahren zur verwendung von guava-extrakt und zusammensetzung mit guava-extrakt
MX2009005950A (es) Compuestos inhibidores de fosfoinositido 3-quinasas y metodos de uso.
MX2009003160A (es) Formas cristalinas del acido 3-[5-(2-fluorofenil)-[1,2,4]oxadiazol -3-il]-benzoico.
ATE375810T1 (de) Cyanoamid-verbindungen als nützliche malonyl-coa decarboxylase-hemmer
RU2009138327A (ru) Композиции и способы направленного устранения мутационного ускользания в направленной терапии рака
HK1133596A1 (en) Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
IL166657A0 (en) Pharmaceutical compositions containing an agent effective to reduce the effective amount of clusterin
MX2009011749A (es) Compuestos triciclicos como inhibidores de metaloproteinasa matricial.
WO2008157537A3 (en) Compositions and methods of use for treating or preventing lipid related disorders
DE602004030017D1 (de) Heterocyclische verbindungen als nützliche malonyl-coa decarboxylase-hemmer
UA94922C2 (ru) Способ регулирования специфичности сигнализации тканевого фактора у млекопитающего, которое нуждается в этом, способ идентификации агента, который специфически ингибирует сигнализацию тканевого фактора
TW200738251A (en) Transcription modulator compositions
MX2010009371A (es) Composiciones para el cuidado del pelo y metodos para incrementar el diametro del pelo.
WO2008030752A3 (en) Methods for determining effective doses of fatty acid amide hydrolase inhibitors in vivo
ATE341539T1 (de) Malonyl coa-decarboxylase inhibitoren als stoffwechselmodulatoren
DE602004014937D1 (de) Piperidin-verbindungen als malonyl-coa decarboxylase-hemmer
MX366496B (es) Metodos para preparar composiciones farmaceuticas que comprenden acetato de eslicarbazepina y metodos de uso.
NZ585338A (en) Insulin-regulated aminopeptidase (irap) inhibitors and uses thereof
TW200735863A (en) Dietary compositions for enhancing metabolism and reducing reactive oxygen species